The present invention relates to quinone-derived compounds with leishmanicidal activity and their use in the pharmaceutical sector, specifically in the field of parasitic diseases. Specifically, it relates to compound I, its isomeric forms, and salts thereof. same.
High efficiency
Low toxicity.
Significant improvement compared to the reference treatment with Miltefosine.
Synthetic process using readily available and low-cost commercial compounds instead of extraction from the natural source.